Cargando…

Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access

IMPORTANCE: Buprenorphine is underutilized as a treatment for opioid use disorder (OUD); state policies may improve buprenorphine access and utilization. OBJECTIVE: To assess buprenorphine prescribing trends following New Jersey Medicaid initiatives designed to improve access. DESIGN, SETTING, AND P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treitler, Peter, Nowels, Molly, Samples, Hillary, Crystal, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163388/ https://www.ncbi.nlm.nih.gov/pubmed/37145594 http://dx.doi.org/10.1001/jamanetworkopen.2023.12030

Ejemplares similares

Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
por: Dowd, William N., et al.
Publicado: (2022)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2020)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2023)

Assessment of Medicaid Beneficiaries Included in Community Engagement Requirements in Kentucky
por: Venkataramani, Atheendar S., et al.
Publicado: (2019)

Association of Medicaid Eligibility With Surgical Readmission Among Medicare Beneficiaries
por: Cher, Benjamin A. Y., et al.
Publicado: (2020)

New Jersey's Medicaid waiver for acquired immunodeficiency syndrome
por: Merzel, Cheryl, et al.
Publicado: (1992)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Access of Rural AFDC Medicaid Beneficiaries to Mental Health Services
por: Lambert, David, et al.
Publicado: (1995)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Home-Care Use and Expenditures Among Medicaid Beneficiaries with AIDS
por: Sambamoorthi, Usha, et al.
Publicado: (1999)

Health Care Access, Use, and Satisfaction Among Disabled Medicaid Beneficiaries
por: Coughlin, Teresa A., et al.
Publicado: (2002)

Access and Use of Health Services by Chronically Mentally III Medicaid Beneficiaries
por: Moscovice, Ira, et al.
Publicado: (1993)

Medicaid Highlights: Trends in Medicaid Prescribed Drug Expenditures and Utilization
por: Tepper, Carl D., et al.
Publicado: (2004)

Adoption of Emergency Department–Initiated Buprenorphine for Patients With Opioid Use Disorder: Secondary Analysis of a Cluster Randomized Trial
por: Gao, Evangeline, et al.
Publicado: (2023)

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Association of Prepregnancy Body Mass Index With Risk of Severe Maternal Morbidity and Mortality Among Medicaid Beneficiaries
por: Frey, Heather A., et al.
Publicado: (2022)

Association of Primary Care Physicians’ Individual- and Community-Level Characteristics With Contraceptive Service Provision to Medicaid Beneficiaries
por: Bodas, Mandar, et al.
Publicado: (2023)

Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits
por: Kaufman, Brystana G., et al.
Publicado: (2023)

DataView: Trends and Current Drug Utilization Patterns of Medicaid Beneficiaries
por: Lied, Terry R., et al.
Publicado: (2006)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge
por: Solomon, Keisha T., et al.
Publicado: (2023)

Utilization of Services in Arizona's Capitated Medicaid Program for Long-Term Care Beneficiaries
por: McCall, Nelda, et al.
Publicado: (1997)

The impact of Medicaid expansion on spending and utilization by older low‐income Medicare beneficiaries
por: Mellor, Jennifer M., et al.
Publicado: (2023)

Medicaid Highlights: 2003 Medicaid Versus Commercial Beneficiary Experience with Care
por: Lied, Terry R.
Publicado: (2005)

Associations Between a New York City Paid Sick Leave Mandate and Health Care Utilization Among Medicaid Beneficiaries in New York City and New York State
por: Ko, Hansoo, et al.
Publicado: (2021)

Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
por: Rao, Tanvi, et al.
Publicado: (2020)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

Trends in Postacute Care Use and Outcomes After Hip and Knee Replacements in Dual-Eligible Medicare and Medicaid Beneficiaries, 2013-2016
por: Li, Yue, et al.
Publicado: (2020)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

The effect on dental care utilization from transitioning pediatric Medicaid beneficiaries to managed care
por: Nasseh, Kamyar, et al.
Publicado: (2022)

Hospital Use and Mortality Among Decarcerated Individuals With Substance Use Disorder After a Large-scale COVID-19 Emergency Prison Release Program
por: Treitler, Peter, et al.
Publicado: (2023)

Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
por: Oh, GYeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4knv8mpej9a884ur0urmtk4uk9